Lindeman Erik, Bäckberg Matilda, Personne Mark, Helander Anders
Läkemedelsverket - Giftinformationscentralen Stockholm, Sweden Läkemedelsverket - Giftinformationscentralen Stockholm, Sweden.
- Stockholm, Sweden - Stockholm, Sweden.
Lakartidningen. 2014 Sep 11;111(40):1712-5.
During the last years several synthetic opioids have been introduced on Internet sites selling new psychoactive substances (NPS). One of these, called MT-45, a piperazine derivative originally synthesized as a therapeutic drug candidate in the 1970s, has recently been detected in 21 deaths, according to unpublished data from the Swedish National Board of Forensic Medicine. We present clinical data from 12 analytically confirmed hospital cases of MT-45 poisoning. The cases demonstrate that MT-45, like other opioids, can induce potentially life threatening respiratory depression and loss of consciousness in users and that symptoms are usually reversed by standard doses of the opioid receptor antagonist naloxone. Significant auditory symptoms with transient tinnitus and hearing loss occurred in two cases and a pronounced sensorineural hearing loss still present at two weeks follow-up in one case. This indicates that MT-45 may be an ototoxic substance, illustrating the ubiquitous risk of unintended adverse effects NPSs pose to users.
在过去几年里,几种合成阿片类药物出现在销售新型精神活性物质(NPS)的网站上。其中一种名为MT - 45的哌嗪衍生物,最初于20世纪70年代作为治疗药物候选物合成,根据瑞典国家法医委员会未发表的数据,最近在21起死亡事件中被检测到。我们展示了12例经分析确认的MT - 45中毒住院病例的临床数据。这些病例表明,MT - 45与其他阿片类药物一样,可导致使用者出现潜在危及生命的呼吸抑制和意识丧失,且症状通常可通过标准剂量的阿片受体拮抗剂纳洛酮逆转。两例出现了伴有短暂耳鸣和听力损失的明显听觉症状,一例在两周随访时仍存在明显的感音神经性听力损失。这表明MT - 45可能是一种耳毒性物质,说明了新型精神活性物质给使用者带来意外不良影响的普遍风险。